VHCP Management II, LLC Portfolio Holdings - 13F Filings | 13F Fund Database
VHCP Management II, LLC 13F Holdings
CIK 0001602263
As of Dec 31, 2019, VHCP Management II, LLC reported
20 positions worth $379.4K in its SEC Form 13F filing.
Top 20 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
| 10X GENOMICS INC | TXG | Healthcare | 1,786,431 |
|
36.2K
35.91% |
| AXSOME THERAPEUTICS INC | AXSM | Healthcare | 785,981 | $81.2K | 21.42% |
| CONSTELLATION PHARMACEUTICALS INC. | CNST | Healthcare | 1,500,631 | $70.7K | 18.64% |
| Biohaven Pharmactl Hldg Co L | — | — | 462,903 | $25.2K | 6.64% |
| SHOCKWAVE MED INC | — | — | 288,838 |
2.7K | 3.34% |
| IVERIC BIO INC | — | — | 1,004,299 | $8.6K | 2.27% |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 366,268 | $6.5K | 1.72% |
| OBSEVA SA | OBSVF | Healthcare | 1,573,639 | $6.0K | 1.58% |
| MERSANA THERAPEUTICS INC | MRSN | Healthcare | 922,514 | $5.3K | 1.39% |
| SPERO THERAPEUTICS INC | SPRO | Healthcare | 474,015 | $4.6K | 1.20% |
| RELMADA THERAPEUTICS INC COM | RLMD | — | 114,876 | $4.5K | 1.18% |
| ADVERUM BIOTECHNOLOGIES INC | ADVM | Healthcare | 383,620 | $4.4K | 1.16% |
| MARINUS PHARMACEUTICALS INC | MRNS | Healthcare | 1,486,676 | $3.2K | 0.85% |
| FORTY SEVEN INC | FTSV | Healthcare | 77,714 | $3.1K | 0.81% |
| MILESTONE PHARMACEUTICALS IN | MIST | — | 148,560 | $2.4K | 0.63% |
| NEXTCURE INC | — | — | 36,249 | $2.0K | 0.54% |
| MYOVANT SCIENCES LTD | MYOV | Healthcare | 76,768 |
.2K | 0.31% |
| 89BIO INC | ETNB | Healthcare | 41,235 |
.1K | 0.29% |
| BELLEROPHON THERAPEUTICS INC | BLPH | Healthcare | 659,087 | $230.0 | 0.06% |
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 32,211 | $227.0 | 0.06% |